Clinical potential of GM-CSF in HIV-infected patients: Studies at the Memorial Sloan Kettering Cancer Center.
Krown
S E
SE
Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Paredes
J
J
Gold
J W
JW
Bundow
D
D
Anselmo
W
W
O'Boyle
K
K
Flomenberg
N
N
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000628:therapy*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control*; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000150:complications / Q000628:therapy; D015215:Zidovudine / Q000009:adverse effects* / Q000627:therapeutic use
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D015215:Zidovudine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor